Raphael Mayer is the owner of Smart Assays Biotechnologies Ltd., specializing in customized R&D services for biotechnology and pharmaceutical companies. Prior to this, Raphael held various roles including CTO at Affisink Biotechnologies, Head of Assays Development at Quark Pharmaceuticals, and Team Leader at InSight BioPharmaceuticals. Raphael holds a Ph.D. in Biological Chemistry from The Hebrew University of Jerusalem and was a Postdoctoral Fellow in Plant Signal Transduction at The Rockefeller University.
Sign up to view 3 direct reports
Get started
This person is not in any teams